Strength Seen in SpringWorks Therapeutics (SWTX): Can Its 6.0% Jump Turn into More Strength?

SpringWorks Therapeutics (SWTX) shares ended the last trading session 6% higher at $41.20. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 7.2% loss over the past four weeks.The company’s sole marketed drug, Ogsiveo, which is approved for treating adult patients with progressing desmoid tumors, has been witnessing a strong initial uptake. The growing optimism surrounding Ogsiveo might have driven the recent share p ...